Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development

Brain, Behavior, and Immunity

Volumn 47, Issue , 2015, Pages 44-57

  Jacob, Louis ^a   Leib, Ryan ^b   Ollila, Hanna M ^a   Bonvalet, Mélodie ^a   Adams, Christopher M ^b   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

2D DIGE; Arepanrix; H1N1; Influenza A; Mass spectrometry; Narcolepsy; Pandemrix; Vaccine

Indexed keywords

BINDING PROTEIN; FATTY ACID BINDING PROTEIN; HEART FATTY ACID BINDING PROTEIN; HEMAGGLUTININ HA1; HEMAGGLUTININ HA2; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MATRIX PROTEIN; PROGRAMMED CELL DEATH 6 INTERACTING PROTEIN; TETRASPANIN; TETRASPANIN 8; TUBULIN; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; VIRUS SIALIDASE; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; DEAMINATION; MASS SPECTROMETRY; NARCOLEPSY; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SULFATION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ADVERSE EFFECTS; COMPARATIVE STUDY; HUMAN; INFLUENZA, HUMAN; METABOLISM; VACCINATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS SPECTROMETRY; NARCOLEPSY; VACCINATION; VIRAL PROTEINS;

EID: 84930759548     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.11.004     Document Type: Article

References (63)

1. Ahmed S.Sohail, Schur Peter H., Macdonald Noni E., Steinman Lawrence Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J. Autoimmun. 2014, 50C:1-11. 10.1016/j.jaut.2014.01.033.
2. Aran Adi, Lin Ling, Nevsimalova Sona, Plazzi Giuseppe, Hong Seung Chul, Weiner Karin, Zeitzer Jamie, Mignot Emmanuel Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009, 32(8):979-983.
3. Assessment Report for Arepanrix-European Medicines Agency, 2010. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001201/WC500089740.pdf.
4. Assessment Report for Focetria, European Medicines Agency, 2009. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000710/WC500023755.pdf.
5. Bergman Peter, Adori Csaba, Vas Szilvia, Kai-Larsen Ylva., Sarkanen Tomi, Cederlund Andreas, Agerberth Birgitta, et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl. Acad. Sci. 2014, 111(35):E3735-E3744. 10.1073/pnas.1412189111.
6. Berlett Barbara S., Stadtman Earl R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272(33):20313-20316. 10.1074/jbc.272.33.20313.
7. Billiard M. Narcolepsy, clinical features and aetiology. Ann. Clin. Res. 1985, 17(5):220-226.
8. Bosch F.X. Studies on the development of the charge heterogeneity of the influenza virus glycoproteins. Arch. Virol. 1985, 83(3-4):311-317.
9. Calabro Samuele, Tritto Elaine, Pezzotti Annamaria, Taccone Marianna, Muzzi Alessandro, Bertholet Sylvie, De Gregorio Ennio, O'Hagan Derek T., Baudner Barbara, Seubert Anja The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. Vaccine 2013, 31(33):3363-3369. 10.1016/j.vaccine.2013.05.007.
10. Chaloupka I., Schuler A., Marschall M., Meier-Ewert H. Comparative analysis of six European influenza vaccines. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15(2):121-127.
11. Chen F.T., Dobashi T.S., Evangelista R.A. Quantitative analysis of sugar constituents of glycoproteins by capillary electrophoresis. Glycobiology 1998, 8(11):1045-1052.
12. Chen Yun-Hsiang, Huang Yu-Shu, Chien Wei-Hsien, Chen Chia-Hsiang Association analysis of the major histocompatibility complex, Class II, DQ β1 gene, HLA-DQB1, with narcolepsy in Han Chinese patients from Taiwan. Sleep Med. 2013, 14(12):1393-1397. 10.1016/j.sleep.2013.06.017.
13. Clarke Steven Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int. J. Pept. Protein Res. 1987, 30(6):808-821. 10.1111/j.1399-3011.1987.tb03390.x.
14. Dauvilliers Y., Maret S., Bassetti C., Carlander B., Billiard M., Touchon J., Tafti M. A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1. Neurology 2004, 62(11):2137-2138.
15. Dauvilliers Yves, Arnulf Isabelle, Lecendreux Michel, Charley Christelle Monaca, Franco Patricia, Drouot Xavier, d'Ortho Marie-Pia, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013, 136(Pt 8):2486-2496. 10.1093/brain/awt187.
16. Dauvilliers Yves, Montplaisir Jacques, Cochen Valeerie, Desautels Alex, Einen Mali, Lin Ling, Kawashima Minae, et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010, 33(11):1428-1430.
17. Dell Anne, Galadari Alaa, Sastre Federico, Hitchen Paul Similarities and differences in the glycosylation mechanisms in prokaryotes and eukaryotes. Int. J. Microbiol. 2010, 2010. 10.1155/2010/148178.
18. Duffy Jonathan, Weintraub, Claudia Vellozzi, Frank DeStefano, and On behalf of the Vaccine Safety Datalink Eric, Vellozzi Claudia, DeStefano Frank Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014, On behalf of the Vaccine Safety Datalink. 10.1212/WNL.0000000000000987.
19. Epstein Suzanne L., Kong Wing-pui, Misplon Julia A., Lo Chia-Yun, Tumpey Terrence M., Ling Xu, Nabel Gary J. Protection against multiple influenza a subtypes by vaccination with highly conserved nucleoprotein. Vaccine 2005, 23(46-47):5404-5410. 10.1016/j.vaccine.2005.04.047.
20. Faraco Juliette, Lin Ling, Kornum Birgitte Rahbek, Kenny Eimear E., Trynka Gosia, Einen Mali, Rico Tom J., et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet. 2013, 9(2). 10.1371/journal.pgen.1003270.
21. Geiger T., Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. succinimide-linked reactions that contribute to protein degradation. J. Biol. Chem. 1987, 262(2):785-794.
22. Hallmayer Joachim, Faraco Juliette, Lin Ling, Hesselson Stephanie, Winkelmann Juliane, Kawashima Minae, Mayer Geert, et al. Narcolepsy is strongly associated with the TCR alpha locus. Nat. Genet. 2009, 41(6):708-711. 10.1038/ng.372.
23. Han Fang, Faraco Juliette, Dong Xiao Song, Ollila Hanna M., Lin Ling, Li Jing, An Pei, et al. Genome wide analysis of narcolepsy in china implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet. 2013, 9(10). 10.1371/journal.pgen.1003880.
24. Han Fang, Lin Ling, Li Jing, Dong Xiao Song, Mignot Emmanuel Decreased incidence of childhood narcolepsy 2years after the 2009 H1N1 winter flu pandemic. Ann. Neurol. 2013, 73(4):560. 10.1002/ana.23799.
25. Han Fang, Lin Ling, Warby Simon C., Faraco Juliette, Li Jing, Dong Song X., An Pei, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann. Neurol. 2011, 70(3):410-417. 10.1002/ana.22587.
26. Heier M.S., Gautvik K.M., Wannag E., Bronder K.H., Midtlyng E., Kamaleri Y., Storsaeter J. Incidence of narcolepsy in norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 2013, 14(9):867-871. 10.1016/j.sleep.2013.03.020.
27. Highlights of Prescription Informations for Flulaval (GSK), 2014. https://www.gsksource.com/gskprm/htdocs/documents/FLULAVAL.PDF.
28. Honda Y. Census of narcolepsy cataplexy and sleep life among teenagers in Fujisawa city. Sleep Res 1979.
29. ICSD3, 2014. American Academy of Sleep Medicine.
30. Lavie P., Peled R. Narcolepsy is a rare disease in Israel. Sleep 1987, 10(6):608-609.
31. Longstreth W.T., Koepsell Thomas D., Ton Thanh G., Hendrickson Audrey F., van Belle Gerald. The epidemiology of narcolepsy. Sleep 2007, 30(1):13-26.
32. Longstreth W.T., Thanh Ton G.N., Koepsell Thomas D. Narcolepsy and streptococcal infections. Sleep 2009, 32(12):1548.
33. Medina Rafael A., Stertz Silke, Manicassamy Balaji, Zimmermann Petra, Sun Xiangjie, Albrecht Randy A., Uusi-Kerttula Hanni, et al. Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses. Sci. Trans. Med. 2013, 5(187):187ra70. 10.1126/scitranslmed.3005996.
34. Melén Krister, Partinen Markku, Tynell Janne, Sillanpää Maarit, Himanen Sari-Leena, Saarenpää-Heikkilä Outi, Hublin Christer, et al. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. PLoS One 2013, 8(8):e68402. 10.1371/journal.pone.0068402.
35. Mendes Mirian Fabiola, Gurgel Studart, de Campos Dirceu, Neto Valladares, Aparecida de Azevedo Rosangela, Caramelli Paulo Narcolepsy after A/H1N1 vaccination. Clinics 2012, 67(1):77-78. 10.6061/clinics/2012(01)12.
36. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998, 50(2 Suppl. 1):S16-S22.
37. *0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997, 20(11):1012-1020.
38. *15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997, 49(4):329-341.
39. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., Okun M., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 2001, 68(3):686-699.
40. Miller Elizabeth, Andrews Nick, Stellitano Lesley, Stowe Julia, Winstone Anne Marie, Shneerson John, Verity Christopher Risk of narcolepsy in children and young people receiving AS03 adjuvanted Pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ (Clinical Research Ed.) 2013, 346:f794.
41. Montplaisir Jacques, Petit Dominique, Quinn Marie-Josée, Ouakki Manale, Deceuninck Geneviève, Desautels Alex, Mignot Emmanuel, De Wals Philippe Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014, 9(9):e108489. 10.1371/journal.pone.0108489.
42. Narcolepsy in Association with Pandemic Influenza Vaccines, 2012. European center for disease prevention and control. http://www.ecdc.europa.eu/en/publications/publications/vaesco%20report%20final%20with%20cover.pdf.
43. Nicolson Carolyn, Harvey Ruth, Johnson Rachel, Guilfoyle Kate, Engelhardt Othmar G., Robertson James S. An additional oligosaccharide moiety in the HA of a Pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine 2012, 30(4):745-751. 10.1016/j.vaccine.2011.11.081.
44. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355(9197):39-40. 10.1016/S0140-6736(99)05582-8.
45. Nohynek Hanna, Jokinen Jukka, Partinen Markku, Vaarala Outi, Kirjavainen Turkka, Sundman Jonas, Himanen Sari-Leena, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012, 7(3):e33536. 10.1371/journal.pone.0033536.
46. O'Flanagan D., Barret A.S., Foley M., Cotter S., Bonner C., Crowe C., Lynch B., et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010. Euro. Surveill. 2014, 19(17):15-25.
47. Partinen Markku, Saarenpaa-Heikkila Outi, Ilveskoski Ismo, Hublin Christer, Linna Miika, Olsen Paivi, Nokelainen Pekka, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012, 7(3). 10.1371/journal.pone.0033723.
48. Persson I., Granath F., Askling J., Ludvigsson J.F., Olsson T., Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2years of follow-up. J. Intern. Med. 2014, 275(2):172-190. 10.1111/joim.12150.
49. Peyron C. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 2000, 6:991-997. 10.1038/79690.
50. Privalsky M.L., Penhoet E.E. Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis. Proc. Natl. Acad. Sci. U.S.A. 1978, 75(8):3625-3629.
51. R Core Team, 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL. 2014. http://www.R-Project.org/.
52. Robertson James S., Nicolson Carolyn, Harvey Ruth, Johnson Rachel, Major Diane, Guilfoyle Kate, Roseby Sarah, et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011, 29(9):1836-1843. 10.1016/j.vaccine.2010.12.044.
53. Skowronski Danuta M., Janjua Naveed Z., De Serres Gaston., Sabaiduc Suzana, Eshaghi Alireza, Dickinson James A., Fonseca Kevin, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014, 9(3):e92153. 10.1371/journal.pone.0092153.
54. Stephenson R.C., Clarke S. Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J. Biol. Chem. 1989, 264(11):6164-6170.
55. Summary of Product Characteristics-H5N1, 2014. http://ec.europa.eu/health/documents/community-register/2011/20110418101870/anx_101870_en.pdf.
56. Summary of Product Characteristics-Pandemrix, 2010. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000832/WC500038121.pdf.
57. Tashiro T., Kanbayashi T., Hishikawa Y. An epidemiological study on prevalence of narcolepsy in Japanese. Sleep Res 1992.
58. Wang Wei, Castelán-Vega Juan A., Jiménez-Alberto Alicia, Vassell Russell, Ye Zhiping, Weiss Carol D. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Virology 2010, 407(2):374-380. 10.1016/j.virol.2010.08.027.
59. Wijnans Leonoor, Lecomte Coralie, de Vries Corinne, Weibel Daniel, Sammon Cormac, Hviid Anders, Svanström Henrik, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013, 31(8):1246-1254. 10.1016/j.vaccine.2012.12.015.
60. Winstone Anne Marie, Stellitano Lesley, Verity Christopher, Andrews Nick, Miller Elizabeth, Stowe Julia, Shneerson John Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev. Med. Child Neurol 2014, 10.1111/dmcn.12522.
61. Wise M.S. Childhood narcolepsy. Neurology 1998, 50(2 Suppl. 1):S37-S42.
62. Ye Qiaozhen, Krug Robert M., Tao Yizhi Jane The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 2006, 444(7122):1078-1082. 10.1038/nature05379.
63. Zhirnov O., Bukrinskaya A.G. Nucleoproteins of animal influenza viruses. Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells 1984, 65(Pt 6):1127-1134.